Filing Flows › Comparisons › NAUT vs ASTC
Nautilus Biotechnology vs Astrotech: NAUT and ASTC compared
Nautilus Biotechnology is the larger company: $234K of revenue in its latest quarter (Q3 2026) against $126K for Astrotech (Q4 FY26).
Where the money goes: NAUT and ASTC
Nautilus Biotechnology (NAUT) · Q3 2026
Nautilus Biotechnology, Q3 2026: revenue $234K, net loss $15.6M, operating cash flow −$13.3M. The chart follows the revenue to costs, profit and cash.
Astrotech (ASTC) · Q4 FY26
Astrotech, Q4 FY26: revenue $126K (-43% year over year), net loss $3.3M, operating cash flow −$2.3M. The chart follows the revenue to costs, profit and cash.
| Nautilus Biotechnology (NAUT) | Astrotech (ASTC) | |
|---|---|---|
| Latest quarter | Q3 2026 | Q4 FY26 |
| Revenue | $234K | $126K |
| Revenue growth, Y/Y | — | -43% |
| Operating margin | n/m | n/m |
| Net earnings | −$15.6M | −$3.3M |
| Operating cash flow | −$13.3M | −$2.3M |
Questions
Which is bigger, Nautilus Biotechnology or Astrotech?
Nautilus Biotechnology is the larger company: $234K of revenue in its latest quarter (Q3 2026) against $126K for Astrotech (Q4 FY26).
More: Nautilus Biotechnology earnings · how Nautilus Biotechnology makes money · Astrotech earnings · how Astrotech makes money
From the companies' latest 10-Q, 10-K or earnings release (10-Q filed Oct 27, 2026; 10-K filed Sep 25, 2026). Fiscal quarters can end on different dates. Not investment advice.